Freedom Leaf

OCTOBER 15, 2018

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. schedules were created by the Controlled Substances Act (CSA) in 1970 and are interpreted and enforced by the DEA. More CBD Coverage.

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

Cannabis Law Report

NOVEMBER 11, 2021

On November 3, 2021, New York’s Cannabis Control Board (CCB) held its third public meeting during which it made additional progress in developing the regulatory landscape contemplated by the Marijuana Regulation and Taxation Act (MRTA). Cannabinoid Hemp Program Regulations (Finally) Finalized.

Programs 52

Programs Hemp Supply Chain Seed-To-Sale 52

Canna Law Blog

SEPTEMBER 6, 2023

The HHS news means that the country’s top health agency has finally conceded that cannabis has medical value, and isn’t a drug of abuse on par with fentanyl or heroin. If cannabis goes from a Schedule I to a Schedule III, the cannabis industry as we know it will forever change. if the plant is moved to Schedule III.

Research and Development 112

Research and Development DEA Marijuana Pharmaceutical 112

Cannabis Law Report

JULY 23, 2021

On Wednesday, July 14, 2021 Senators Chuck Schumer (D-NY), Cory Booker (D-NJ), and Ron Wyden (D-OR) released draft legislation titled the Cannabis Administration and Opportunity Act. If implemented, regulatory responsibility of cannabis would be transferred from the U.S. Draft Bill Details.

Research and Development 105

Research and Development DEA Programs State Laws 105

The Cannigma

MAY 15, 2023

Ketamine has a long safety record as an anesthetic since the 1980s, and it has also been successfully used “off-label” for over a decade to treat conditions such as anxiety, depression, OCD, and PTSD, among others. What is treatment like through an at-home ketamine program? At-home ketamine treatment programs vary.

Therapy 78

Therapy Access Blood Pressure Treatment 78

Veriheal

APRIL 11, 2022

Cannabis, despite being widely available for medical and recreational consumers across the United States, remains one of the most understudied plants. federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Drug Enforcement Agency (DEA).

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Project CBD

AUGUST 23, 2023

A leading California cannabis industry policy influencer, Devitt is currently Director of Regulatory Affairs at CannaCraft & March and Ash. Current Market Dynamics Loopholes in the 2018 Farm Bill The 2018 Farm Bill defines “hemp” as “the plant Cannabis sativa L.

Cannabinoids 141

Cannabinoids Hemp THC Safety 141

Cannabis Law Report

JULY 2, 2019

LegitScript, the global leader in merchant and product certification and monitoring in the e-commerce and payment sectors, has launched a new certification program for legally compliant CBD products and websites. LegitScript’s CEO, John Horton, said the program will bring transparency and structure to the CBD industry.

Compliance 40

Compliance Compliance Programs CBD 40

The Blunt Truth

MAY 15, 2020

The big news this week is that cannabis banking is included in the latest federal relief bill. Maine made changes to their marijuana program. cannabis banking. We reported last week on the DOJ’s memo finding that the Drug Enforcement Administration’s cannabis research program is non-compliant with international drug laws.

Banking 106

Banking Research and Development Programs Advocacy 106

SMPL

MAY 6, 2020

Since 1968, scientists pursuing marijuana research have had to obtain their cannabis from a 12-acre farm located at the University of Mississippi. Thanks to a lawsuit spearheaded by the Scottsdale Research Institute (SRI) and cannabis researcher Sue Sisley, the public now understands why. Lawmakers like Sens.

DEA 40

DEA Marijuana Programs Cultivation 40

Canna Law Blog

OCTOBER 26, 2020

A few weeks ago, we wrote about the lawsuit filed by the California Bureau of Cannabis Control (BCC) against Vertical Bliss, Inc. , a company which the BCC alleged had manufactured cannabis products and sold them unlawfully in the illicit market. That said, we fully expect that over the next year, the agencies will ramp up enforcement.

Compliance 79

Compliance Compliance DEA Business 79

Cannabis Law Report

JULY 28, 2022

Colorado could decriminalize the personal use and possession of certain psychedelic plants and fungi, including “magic mushrooms,” and create a Natural Medicine Access Program, according to a voter initiative on the November ballot. To sign up for a free subscription to Food Safety News, click here.). Blog: Food Safety News.

Legalization 52

Legalization Decriminalization Food Safety 52

Veriheal

JUNE 23, 2022

The legalization of cannabis is opening many doors in states that are embracing it. The lack of effective tools to measure cannabis impairment accurately, in practice, encourages the criminalization of legal cannabis in states where a legal grey area exists. Current Testing for Cannabis Impairment Is Not Precise.

Consumption 104

Consumption Legalization Concentrates Patients 104

Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. submitted his first DEA application to manufacture marijuana for use in medical research.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

JANUARY 14, 2020

601 , the “Medical Cannabis Research Act of 2019” H.R. Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research. CLICK IMAGE TO ACCESS COMMITTEE INFO PAGE. Legislation. 171 , the “Legitimate Use of Medicinal Marihuana Act” or the “LUMMA” H.R. Douglas Throckmorton, M.D.

Clinical Trials 69

Clinical Trials Programs Access DEA 69

Cannabis Law Report

JULY 30, 2021

On July 14, 2021, Senators Chuck Schumer (D-NY), Ron Wyden (D-OR), and Cory Booker (D-NJ) released the discussion draft of historic federal cannabis legalization legislation, the Cannabis Administration and Opportunity Act (CAOA). We strongly encourage participation in this important opportunity to shape federal cannabis policy.

Hemp 105

Hemp Law Seed-To-Sale Food 105

Cannabis Law Report

MAY 29, 2022

8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. To mitigate safety risks, FDA implemented a Risk Evaluation and Mitigation Strategy (REMS) with elements to assure safe use (ETASU) whereby patients self-administer the spray in their healthcare provider’s office under medical supervision.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Veriheal

AUGUST 31, 2020

Add onto that the difficulty of these unprecedented times, as a minority-owned business, we’re making it our priority to pay it forward and invest in the future leaders of cannabis who will break barriers and pave the way for innovation in this burgeoning industry. . Veriheal’s Innovation in Cannabis Scholarship 2020 Winners .

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

OCTOBER 31, 2019

The illicit extraction operation was detected by OLCC inspectors at an out-of-compliance Oregon Medical Marijuana Program (OMMP) medical grow site. Inspectors from the OLCC OMMP Marijuana Tracking Program were making a proactive check on the Lane County location which had been registered as an OMMP (GSA) grow site.

Oil 45

Oil Extraction Hash Marijuana 45

Cannabis Law Report

OCTOBER 25, 2019

As president, Bernie will: Legalize marijuana in the first 100 days with executive action by: Nominating an attorney general, HHS secretary, and administrator for the DEA who will all work to aggressively end the drug war and legalize marijuana. Ending The War On Marijuana And Undoing Its Damage.

Programs 55

Programs Safety Access Business 55

SMPL

FEBRUARY 11, 2020

President Trump proposed ending an existing policy that protects state medical marijuana programs from Justice Department interference as part of his fiscal year 2021 budget plan released on Monday. Trump’s last two budgets omitted the medical cannabis protections language, and President Obama similarly asked for the policy to be removed.

Research and Development 40

Research and Development Legalization Marijuana Programs 40

Cannabis Law Report

JULY 28, 2022

An Examination of the USDA Hemp Production Program. Hemp Roundtable Vice President and CEO of Kentucky-based Ecofibre, Eric Wang, testified alongside Kentucky Commissioner of Agriculture, Ryan Quarles, during a Congressional hearing regarding “ An Examination of the USDA’s Hemp Production Program.” Washington D.C.

Agriculture 52

Agriculture Hemp CBD Research and Development 52

Veriheal

AUGUST 24, 2022

This campaign was backed by New Approach PAC, a nationwide political organization that is focused on supporting progressive reform surrounding cannabis and criminal justice policies. So much, in fact, that it actually gained the attention of the DEA , which recently called for an increase in psychedelic production for research purposes.

Legalization 108

Legalization Medicine Decriminalization Research and Development 108

Cannabis Law Report

JUNE 4, 2021

is an industry innovator who has been involved in the growth of many companies in the cannabis industry, and started his relationship with Medical Marijuana Inc. Titus has been involved in the development and investment of several industry-leading cannabis and industrial hemp businesses during his most recent career.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

Cannabis Law Report

AUGUST 5, 2021

He’s the author of four books on finance and entrepreneurship and is known as one of the leading cannabis finance attorneys in the U.S., having served most recently as Co-Lead of the 60-lawyer Cannabis Practice Group for an AmLaw 100 law firm. There will also be a role for the Treasury and the Consumer Product Safety Commission.

Banking 111

Banking Vaping Education DEA 111

Canna Law Blog

NOVEMBER 16, 2021

I feel like we’re living in an upside down world when it comes to cannabis legalization at the federal level. The main reason being that Dems, despite in being in full control of Congress and the White House, just can’t get the ball across the line on a number of cannabis reform bills. Why is Rep.

DEA 87

DEA Business Banking Food 87

Cannabis Law Report

APRIL 14, 2022

Cannabis cultivation and processing are rapidly-growing industries, as hemp and both recreational and medical marijuana products are being legalized across the country. by eating or smoking cannabis) are unknown. Accordingly, state pesticide programs have tried to provide some clarity to fill the gap left by EPA.

Environment 52

Environment Agriculture Compliance Compliance 52

SpeedWeed

JULY 17, 2021

Senate Majority Leader Chuck Schumer (D-NY) has finally unveiled the first draft of a landmark bill that would end the federal prohibition of cannabis once and for all. . Descheduling cannabis is a critical step towards achieving justice for those targeted and hard hit by the War on Drugs. But that alone is not enough.”.

Legalization 52

Legalization Collective Hash Legislation 52

Cannabis Law Report

JUNE 15, 2021

In addition to eliminating criminal penalties for drug possession at the federal level, the bill also incentivizes state and local governments to adopt decriminalization policies by otherwise limiting their eligibility to receive funds in the Byrne and COPS grant programs. Promotes evidence-based drug education.

Decriminalization 78

Decriminalization Policy Research and Development Data 78

Cannabis Law Report

APRIL 21, 2022

MDMA is a promising psychedelic compound, currently placed by the Drug Enforcement Administration (DEA) in Schedule I of the Controlled Substances Act, that has been produced for legal research in small batches by certified laboratories. The safety and efficacy of MDMA-assisted therapy is currently under investigation.

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

Puff Puff Post

NOVEMBER 11, 2019

Following his announcement of a new “war on drugs” in 1971, Richard Nixon created the Drug Enforcement Administration (DEA) in 1973. The DEA is responsible for curbing narcotic use and the illicit drug trade, and enforcing the Controlled Substances Act (CSA), also signed into law by Nixon in 1970. The Current Legal Status Of Cannabis.

DEA 53

DEA History Legislation Banking 53

Cannabis Law Report

JULY 1, 2021

Mason Marks: The project’s goal is to promote safety, innovation, equity, and accessibility in emerging psychedelics industries. Things have changed a little in the past twenty years, when the DEA gave some researchers permission to study limited amounts of certain psychedelics. POPLAR will publish original law and policy research.

Law 105

Law Research and Development Therapy DEA 105

Cannabis Law Report

JULY 14, 2021

The Cannabis Administration and Opportunity Act and comes in at a hefty 163PP. This is big: Today @SenBooker @SenSchumer and I are releasing our draft legislation to end the federal prohibition of cannabis. Senate Leadership Releases Draft Legislation to Make Cannabis Federally Legal. First here’s the story.

Legislation 71

Legislation Banking History Access 71

WeedAdvisor

SEPTEMBER 16, 2019

In just the past few weeks, this cannabinoid became the backbone of booming medical cannabis industries, especially in South America and some select parts of Europe. But now, cannabidiol, the cannabis product hailed for its multitude of (still being researched) health benefits, could pose a serious risk when purchased from the wrong source.

CBD 45

CBD Vaping DEA Oil 45

Cannabis Law Report

JULY 9, 2021

Drug Enforcement Agency (“DEA”). Some physicians and therapists have argued that the Right to Try Act permits them to administer psilocybin to terminally ill patients (since studies are well past the Phase 1 stage), but the DEA has met this with resistance given psilocybin’s status as a Schedule I drug. AIMS Institute, PLLC.

Law 105

Law Therapy Clinical Trials Research and Development 105

PrestoDoctor

JANUARY 14, 2020

For individuals who need marijuana or cannabis for medical reasons, they must get an MMJ. Who Monitors This Program in Oklahoma? The Oklahoma Medical Marijuana Authority (OMMA) manages the MMJ program for the State of Oklahoma. The Oklahoma Medical Marijuana Authority (OMMA) manages the MMJ program for the State of Oklahoma.

Marijuana 52

Marijuana Patients Conditions Programs 52

PrestoDoctor

JANUARY 14, 2020

For individuals who need marijuana or cannabis for medical reasons, they must get an MMJ. Who Monitors This Program in Oklahoma? The Oklahoma Medical Marijuana Authority (OMMA) manages the MMJ program for the State of Oklahoma. The Oklahoma Medical Marijuana Authority (OMMA) manages the MMJ program for the State of Oklahoma.

Marijuana 52

Marijuana Patients Conditions Programs 52